Cholestyramine compositions and method for treating biliary gastritis
US4172120A · kind A · utility
64Cited by
5References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 9, 1978 |
| Grant date | Oct 23, 1979 |
| Priority date | — |
| Expiry date | Mar 9, 1998 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/785
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A solid pharmaceutical composition comprising anhydrous cholestyramine, 0.6 to 1.7 parts by weight of low viscosity grade alginic acid/sodium alginate per weight of cholestyramine, the low viscosity grade alginic acid/sodium alginate having 0 to 75% of the acid groups neutralized, 0.1 to 0.3 parts by weight of citric acid per weight of sodium alginate, and sufficient sodium carbonate or bicarbonate mixtures thereof to neutralize the acid groups of the alginic and citric acids. The compositions may be used in the treatment of conditions associated with duodeno-gastric reflux of bile into the stomach.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.